Diabetes is associated with an increased risk of cancer and reduces post-cancer survival

October 02, 2018

Having diabetes is linked with an increased risk of developing a number of cancers as well as poorer survival following a cancer diagnosis.

The findings, being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany (1-5 October), come from a large observational study comparing over 450,000 people with type 2 diabetes with more than 2 million matched controls over an average of 7 years.

For the most common cancers, individuals with diabetes face a 20% greater risk of developing colorectal cancer and a 5% higher risk of breast cancer compared with their diabetes-free counterparts. People with diabetes already diagnosed with cancer also fare worse, with a 25% and 29% higher chance of dying following a breast and prostate cancer diagnosis (respectively) than their peers without diabetes.

More than 415 million people are living with diabetes worldwide--equivalent to 1 in 11 of the adult population--and this figure is expected to rise to 642 million by 2040. Previous research has suggested a link between type 2 diabetes and an increased risk of cancer. But the relationship between diabetes and cancer remains poorly understood due to limitations of previous studies including: residual confounding, investigation bias, small sample sizes, self-reported information, and reverse causality.

To provide more evidence, Hulda Hrund Bjornsdottir from the Swedish National Diabetes Register (NDR) , Sweden, and colleagues examined the incidence of a number of cancers and post-cancer mortality in 457,473 individuals with type 2 diabetes from the NDR between 1998 and 2014, compared to 2,287,365 gender-, age- and county-matched controls from the general population over an average of 7 years follow up. The researchers adjusted for a range of factors that could have influenced the results including age, sex, education, marital status, and income.

A total of 227,505 people developed cancer over the follow-up period. Diabetes was associated with 11 out of the 12 specific types of cancer investigated in the study.

Diabetes was clearly linked with higher risk of cancers of the liver (people with diabetes were 231% more likely to be diagnosed with liver cancer than those without a history of diabetes over the study period), pancreas (119%), uterus (78%), penis (56%), kidney (45%), gallbladder and bile ducts (32%), stomach (21%), and bladder (20%). There was evidence that those with diabetes were at a reduced risk of prostate cancer (18%) compared to their peers without diabetes. The absolute 5-year risk of developing cancer for the cancer sites highlighted in the study ranged from 0.02% for penis cancer to 1.45% for prostate cancer for people with diabetes.

In addition, for individuals with diabetes, mortality was higher for prostate (29% higher), breast (25%), and colon (9%) cancer compared to their diabetes-free counterparts.

The authors emphasise that although the relative risk of cancer is increased after diabetes, the absolute risk increase is low. "Our findings do not suggest that everyone who has diabetes will go on to develop cancer in later life", says, Bjornsdottir, who led the study.

The findings also suggest that cancers of the pancreas and lung are a growing problem in people with type 2 diabetes. Over a 10 year period, diabetics showed a 38% greater increase in new cases of pancreatic cancer, a 30% greater increase in lung cancer incidence, whereas there was a 26% decrease in uterus cancer incidence compared to their peers without diabetes. For the other cancer types highlighted by the authors, incidence remained similar in people with and without diabetes over the study period.

"Diabetes and cancer share certain risk factors that might contribute to these associations including obesity, smoking and diet are examples of likely key factors", says Bjornsdottir. "However, we assessed the relative importance of 14 risk factors collected in routine practice and found that they contributed very little to cancer prediction."

She adds, "With the number of people with type 2 diabetes doubling over the past 30 years our findings underscore the importance of improving diabetes care. Eating a healthy diet, getting plenty of exercise and maintaining a healthy weight are important factors in diabetes prevention and furthermore cancer prevention. With diabetes being associated with an increased cancer risk and mortality the importance of a healthy lifestyle is clearer than ever. It's also important for health professionals and the public to be aware of the link between diabetes and cancer."


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.